Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma

PURPOSE: The glycolytic enzyme fructose 1,6-bisphosphate aldolase B (ALDOB) is aberrantly expressed and impacts the prognosis in hepatocellular carcinoma (HCC). Hepatic ALDOB loss leads to paradoxical upregulation of glucose metabolism, favoring hepatocellular carcinogenesis. Nevertheless, the relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Wenzhi, Wu, Qianyun, Yu, Xiaofeng, Shen, Mengqin, Zhang, Ruixue, Li, Jiajin, Zhao, Li, Huang, Gang, Liu, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834807/
https://www.ncbi.nlm.nih.gov/pubmed/36644641
http://dx.doi.org/10.3389/fonc.2022.1044902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834807/
https://www.ncbi.nlm.nih.gov/pubmed/36644641
http://dx.doi.org/10.3389/fonc.2022.1044902

Ejemplares similares